Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

On Monday, the S&P/TSX composite index turned positive for the year with a year-to-date price return (not including the yield) of 0.18 per cent. Energy stocks charged higher while gold stocks tumbled. This price momentum is reflected in today’s Breakouts report.

There are 135 stocks on the positive breakouts list (stocks with positive price momentum). Meanwhile, 36 stocks, mostly gold and silver stocks, are on the negative breakouts list (stocks with negative price momentum).

Discussed today is one of the few non-precious metals stocks that is on the negative breakouts list – Jamieson Wellness Inc. (JWEL-T).

Story continues below advertisement

Just weeks ago, on Nov. 6, Jamieson Wellness’ share price closed at a record high of $43.21. Since then, the stock price has plunged nearly 22 per cent with the stock nearing oversold territory. The stock has come under pressure as confidence for a coronavirus vaccine grows. A concern by investors is that the company’s growth has been boosted from the coronavirus with individuals focusing on health and wellness.

Looking out to 2021, investors are worried that we will see a deceleration in growth with tougher year-over-year comparisons. As a result, investors are taking profits off the table, rotating out of this health and wellness stock and buying cyclical stocks.

For now, the downtrend remains intact. This is a stock to watch as the share price drifts down towards the low $30 level. Remember, stocks often overshoot to the upside as well as to the downside. Wait for the stock price to find a bottom and stabilize.

A brief outline is provided below that may serve as a springboard for further fundamental research when conducting your own due diligence.

The company

Toronto-based Jamieson Wellness manufactures and distributes natural health products including vitamins and minerals, supplements, digestive health products, sleep aids, and herbal extracts.

The company’s revenue stems from two business segments, its branded business and its strategic partners business. In 2019, the Jamieson Brands segment represented 89 per cent of adjusted EBITDA (earnings before interest, taxes, depreciation and amortization). The Jamieson brand is the best-selling brand by sales in Canada within the VMS (vitamins, minerals, and supplements) market. Other brands include Progressive, Precision, Iron Vegan and Smart Solutions by Lorna Vanderhaeghe.

Through the company’s Strategic Partners segment, Jamieson Wellness co-manufactures products for blue-chip companies. Last year, this segment represented 11 per cent of adjusted EBITDA.

Story continues below advertisement

In December of 2019, Jamieson Wellness was added to the S&P/TSX composite index.

Quarterly earnings

After the market closed on Nov. 5, the company reported strong third-quarter financial results.

Revenue increased 19.2 per cent year-over-year to $105.6-million, ahead of the Street’s forecast of $99.6-million with growth from both its branded domestic sales as well as international sales. Revenue from the Jamieson Brands segment grew 17.7 per cent year-over-year to $82.6-million with domestic sales increasing 9.5 per cent and international sales expanding 82.2 per cent (led by growth in China). Revenue from the Strategic Partners segment increased 25 per cent to $23-million. Adjusted EBITDA was $22.9-million, surpassing the consensus estimate of $22.1-million and up 18.2 per cent year-over-year. The adjusted EBITDA margin was 21.7 per cent, relatively unchanged from last year (21.9 per cent realized during the same period last year). Adjusted earnings per share came in at 30 cents, a penny ahead of the consensus estimate and up from 24 cents reported last year.

The following day, the share price rallied 6.5 per cent and closed at a record high on high volume with approximately 440,000 shares traded. This is well above the three-month historical daily average trading volume of approximately 200,000 shares.

For now, management is focused on organic, or internal, growth rather than acquisition growth. Expansion in China is a key objective by management given that the country is the second largest vitamin market worldwide.

On the earnings call, President and Chief Executive Officer Mark Hornick said, “Organic growth is the single best source of return for us at the moment. Multiples for acquisitions are extremely high right now but we are so pleased that, in our case, our organic growth opportunities have never been bigger.”

Story continues below advertisement

For 2020, management expects to realize revenue of between $395-million and $400-million, up from its previous guidance of between $385-million and $395-million. Adjusted EBITDA is anticipated to come in at between $86-million and $88-million, at the upper end of its previous target of between $84-million and $88-million. Adjusted earnings per share is expected to be between $1.11 and $1.15, compared to its prior guidance of between $1.08 and $1.15.

Investment thesis

  • Revenue and earnings growth.
  • Dividend growth.
  • Market leadership.
  • Valuation is becoming more attractive given the stock’s correction.
  • Nearing technically oversold levels. However, the downtrend remains intact.
  • Wait for the share price to bottom out, stabilize.

Dividend policy

The company pays its shareholders a quarterly dividend of 12.5 cents per share, or 50 cents per share on a yearly basis, translating to a current annualized dividend yield of 1.5 per cent.

Since the stock was publicly-listed in July 2017, the company has announced four dividend hikes, in Aug. 2018, Aug. 2019, Feb. 2020 and Aug 2020.

Analysts’ recommendations

This small-cap consumer staples stock with a market capitalization of $1.35-million is actively covered by eight analysts, and all eight analysts have buy recommendations.

The firms providing recent research coverage on the company are as follows in alphabetical order: Accountability Research, BMO Nesbitt Burns, Canaccord Genuity, CIBC World Markets, Eight Capital, National Bank Financial, RBC Dominion Securities, and Scotia Capital.

Revised recommendations

Earlier this month, seven analysts raised their expectations.

Story continues below advertisement

  • Canaccord Genuity’s Tania Gonsalves upgraded her recommendation to a “buy” from a “hold” and raised her target price to $48 (the high on the Street) from $35.75.
  • CIBC World Markets’ Matt Bank lifted his target price to $46 from $42.
  • Scotia Capital’s George Doumet raised his target price to $42 from $37.
  • National Bank Financial’s Endri Leno tweaked his target price to $42.75 from $41.50.
  • BMO Nesbitt Burns’ Peter Sklar increased his target price to $45 from $43.
  • RBC Dominion Securities’ Sabahat Khan lifted his target price to $44 from $39.
  • Accountability Research’s Mark Rosen hiked his target price by $5 to $44.

Financial forecasts

The Street is forecasting revenue of $398-million in 2020, up from $345-million reported in 2019, with revenue expected to rise to $429-million in 2021 and $463-million in 2022.  The consensus EBITDA estimates are $87-million in 2020, up from $75.9-million reported in 2019, and anticipated to reach $99-million in 2021 and $107-million in 2022. The consensus earnings per share estimates are $1.14 in 2020, up from 96 cents reported in 2019, and expected to rise to $1.28 in 2021 and $1.43 in 2022.

Earnings expectations have remained intact throughout the coronavirus pandemic. To illustrate, nine months ago (in Feb.), the Street was forecasting revenue of $371-million in 2020 and $396-million in 2021. EBITDA forecasts were $81.6-million for 2020 and $89-million for 2021. The consensus earnings per share estimates were $1.06 for 2020 and $1.17 for 2021. Meanwhile, four months ago (in July), the Street was forecasting revenue of $380-million in 2020 and $406-million in 2021. EBITDA forecasts were $83.7-million for 2020 and $91.9-million for 2021. The consensus earnings per share estimates were $1.09 for 2020 and $1.22 for 2021.

Valuation

According to Bloomberg, the stock is trading at an enterprise value-to-EBITDA multiple of 15.3 times the 2021 consensus estimate, slightly above its historical multiple (since 2017) of 13.8 times but below its peak multiple of over 19 times during this time period.

The stock is trading at a price-to-earnings multiple of 26.5 times the 2021 consensus estimate, above its historical average multiple of 22.8 times but below its peak multiple of approximately 34 times.

The average one-year target price is $44.47, implying the share price has 31 per cent upside potential over the next year. Individual target prices are as follows in numerical order: $42 (from George Doumet at Scotia Capital), $42.75, three at $44, $45, $46, and $48 (from Tania Gonsalves at Canaccord Genuity).

Insider transaction history

In recent days, two board members have been buyers in the public market.

Story continues below advertisement

On Nov. 12, chairman David Williams invested over $366,000 in shares of Jamieson Wellness. He acquired 10,000 shares at a price per share of $36.6835 for an account in which he has control or direction over.

On Nov. 9 and Nov. 10, director Catherine Potechin bought a total of 2,500 shares at an average cost per share of approximately $39.90. The cost of these purchases totaled nearly $100,000.

Chart watch

The stock began trading on the Toronto Stock Exchange in July 2017. Given the stock’s brief trading history, technical analysis is limited.

Year-to-date, the share price is up 31 per cent, outperforming the S&P/TSX Composite Index and the S&P/TSX consumer staples sector index, which are up 0.18 per cent and 3.8 per cent, respectively.

On Nov. 6, the share price closed at a record high of $43.21. Since then, the stock price has declined nearly 22 per cent. Given this correction, the stock is nearing oversold territory with an RSI (relative strength index) reading of 34. Generally, an RSI reading at or below 30 reflects an oversold condition.

Looking at key technical resistance and support levels, the stock has a major ceiling of resistance is around $40, close to its 50-day moving average (at $39.48). Should the share price continue to slide, there is initial technical support between $33 and $34, near its 200-day moving average (at $34.14) and a 50 per cent retracement of its recent price move that took the share price up to over $43 in Nov. from $24 in March. Failing that, there is support around $31.

Story continues below advertisement

The Breakouts file is a technical analysis screen intended to identify companies that are technically breaking out. In addition, this report highlights a company’s dividend policy, analysts’ recommendations, financial forecasts, and provides a brief technical analysis for a security to provide readers with more information.

If a stock appears on the positive breakouts list, this indicates positive price momentum, and that a company may be worthwhile for investors to look at the fundamentals in order to determine if the recent price strength is warranted and will continue. If a security appears on the negative breakouts list, this indicates negative price momentum, and may be indicative of either deteriorating fundamentals or perhaps indicates a buying opportunity.

Securities screened are from the S&P/TSX composite index, the S&P/TSX Small Cap index, as well as Canadian small cap stocks outside of these indexes that have a minimum market capitalization of $200-million.

A technical analysis screen does not replace fundamental analysis, but can help identify companies worth having a closer look at.

Tuesday's breakout stocks

Positive BreakoutsNov. 23 close
AW-UN-TA&W Revenue Royalties Income Fund $31.35
ARE-TAecon Group Inc $16.17
AOI-TAfrica Oil Corp $1.17
AC-TAir Canada $21.69
CLIQ-TAlcanna Inc. $6.19
AP-UN-TAllied Properties REIT $40.65
ALA-TAltaGas Ltd $18.35
HOT-UN-TAmerican Hotel Income Properties REIT LP $3.24
AHC-TApollo HealthCare Corp. $4.08
ATZ-TAritzia Inc. $24.33
AI-TAtrium Mortgage Investment Corp. $12.54
ATA-TATS Automation Tooling Systems Inc $20.74
BLDP-TBallard Power Systems Inc $28.22
BMO-TBank of Montreal $94.84
BNS-TBank of Nova Scotia $63.87
BTE-TBaytex Energy Corp $0.66
BDT-TBird Construction Inc $7.26
BLN-XBlackline Safety Corp. $7.01
BEI-UN-TBoardwalk Real Estate Investment Trust $34.98
BRE-TBridgemarq Real Estate Services $14.69
BAM-A-TBrookfield Asset Management Inc $53.61
BEPC-TBrookfield Renewable Corporation $96.77
BTB-UN-TBTB Real Estate Investment Trust $3.71
CAE-TCAE Inc $32.19
CF-TCanaccord Genuity Group Inc $8.58
CEU-TCanadian Energy Services & Technology Co $1.10
CNQ-TCanadian Natural Resources Ltd $29.79
CWB-TCanadian Western Bank $30.39
CFP-TCanfor Corp $18.26
CFX-TCanfor Pulp Products Inc $5.76
CVE-TCenovus Energy Inc $6.86
GIB-A-TCGI Group Inc $93.50
CIA-TChampion Iron Ltd. $4.47
CIGI-TColliers International Group Inc $114.90
CUF-UN-TCominar Real Estate Investment Trust $9.18
CSU-TConstellation Software Inc $1,634.24
CTS-XConverge Technology Solutions Corp. $3.29
CMMC-TCopper Mountain Mining Corp $1.32
CPG-TCrescent Point Energy Corp $2.37
CRH-TCRH Medical Corp $3.45
UFS-TDomtar Corp. $39.67
D-UN-TDream Office REIT $21.10
ECN-TECN Capital Corp. $6.11
BABY-XElse Nutrition Holdings Inc. $3.57
EFX-TEnerflex Ltd $7.02
EFR-TEnergy Fuels Inc $2.50
ERF-TEnerplus Corp $3.35
EGLX-TEnthusiast Gaming Holdings Inc. $3.15
ERO-TEro Copper Corp. $21.54
EIF-TExchange Income Corp $39.30
EXRO-XExro Technologies Inc. $4.80
EXE-TExtendicare Inc $6.61
FD-XFacedrive Inc. $17.01
FTT-TFinning International Inc $25.14
FM-TFirst Quantum Minerals Ltd $17.59
FRU-TFreehold Royalties Ltd $4.87
FEC-TFrontera Energy Corp. $2.90
GLXY-TGalaxy Digital Holdings Ltd. $7.12
GFL-TGFL Environmental Inc. $34.32
GPV-XGreenPower Motor Company Inc. $36.88
HR-UN-TH&R Real Estate Investment Trust $14.18
HWX-THeadwater Exploration Inc. $1.87
HIVE-XHIVE Blockchain Technologies Ltd. $0.97
HCG-THome Capital Group Inc $29.96
HBM-THudBay Minerals Inc $7.94
HSE-THusky Energy Inc $5.50
IGM-TIGM Financial Inc $34.34
IMCC-CNIM Cannabis Corp. $1.84
IMO-TImperial Oil Ltd $24.01
IFP-TInterfor Corp $18.89
IPCO-TInternational Petroleum Corp. of Sweden $2.74
ITP-TIntertape Polymer Group Inc $23.00
KBL-TK-Bro Linen Inc. $35.45
KEL-TKelt Exploration Ltd $1.94
LB-TLaurentian Bank of Canada $32.21
LNF-TLeon's Furniture Ltd. $19.98
LSPD-TLightspeed POS Inc. $63.11
LUN-TLundin Mining Corp $9.25
MAL-TMagellan Aerospace Corp $9.18
MRE-TMartinrea International Inc $13.47
MKP-TMCAN Mortgage Corp $15.95
DR-TMedical Facilities Corp $7.42
MEG-TMEG Energy Corp $3.63
MRD-TMelcor Developments Ltd $7.69
MX-TMethanex Corp $51.12
MMED-NEMind Medicine Inc. $2.04
ML-XMillennial Lithium Corp. $3.10
MRG-UN-TMorguard North American Residential REIT $15.96
MRT-UN-TMorguard Real Estate Investment Trust $5.05
MTL-TMullen Group Ltd $10.06
OSB-TNorbord Inc $48.76
NOA-TNorth American Construction Group Ltd. $13.08
NTR-TNutrien Ltd. $60.91
ONC-TOncolytics Biotech Inc $3.40
ONEX-TOnex Corp $70.17
ORL-TOrocobre Ltd. $3.68
OVV-TOvintiv Inc. $17.04
POU-TParamount Resources Ltd $3.68
PSI-TPason Systems Inc $7.14
PPL-TPembina Pipeline Corp $33.28
PTM-TPlatinum Group Metals Ltd $3.17
PIF-TPolaris Infrastructure Inc. $15.10
POW-TPower Corp of Canada $29.61
PSK-TPrairieSky Royalty Ltd $10.60
PD-TPrecision Drilling Corp $25.62
QTRH-TQuarterhill Inc. $2.81
RICH-CNRaffles Financial Group Limited $8.90
RFP-TResolute Forest Products Inc. $7.26
REI-UN-TRioCan Real Estate Investment Trust $17.76
RY-TRoyal Bank of Canada $105.60
RUS-TRussel Metals Inc $20.96
SES-TSecure Energy Services Inc $2.16
VII-TSeven Generations Energy Ltd $5.26
SCL-TShawCor Ltd $3.39
SIA-TSienna Senior Living Inc $13.70
SGR-UN-TSlate Grocery REIT $12.16
SOT-UN-TSlate Office REIT $4.12
SLS-XSolaris Resources Inc. $5.72
SLL-XStandard Lithium Ltd. $2.94
RAY-A-TStingray Digital Group Inc. $6.54
SU-TSuncor Energy Inc $21.92
TVE-TTamarack Valley Energy Ltd. $0.96
TF-TTimbercreek Financial Corp. $8.67
TOG-TTORC Oil & Gas Ltd $2.11
TD-TToronto-Dominion Bank $69.80
TOT-TTotal Energy Services Inc $2.89
TXP-TTouchstone Exploration Inc. $2.20
TCL-A-TTranscontinental Inc $18.07
TCW-TTrican Well Service Ltd $1.45
TNT-UN-TTrue North Commercial REIT $6.58
TWC-TTWC Enterprises Ltd. $14.40
VET-TVermilion Energy Inc $5.33
VFF-TVillage Farms International $12.26
WPRT-TWestport Innovations Inc $4.77
WCP-TWhitecap Resources Inc $3.66
Negative Breakouts
AEM-TAgnico Eagle Mines Ltd $84.65
AGI-TAlamos Gold Inc $10.76
AND-TAndlauer Healthcare Group Inc. $39.17
AR-TArgonaut Gold Inc $2.30
BTO-TB2Gold Corp $7.09
ABX-TBarrick Gold Corp $30.38
BSX-TBelo Sun Mining Corp $0.93
DPM-TDundee Precious Metals Inc $7.81
EQX-TEquinox Gold Corp. $12.86
FVI-TFortuna Silver Mines Inc $8.05
GAU-TGaliano Gold Inc. $1.45
GSV-TGold Standard Ventures Corp. $0.85
GSC-TGolden Star Resources Ltd. $4.80
GOLD-TGoldMining Inc. $2.71
IMG-TIAMGOLD Corp $4.28
JWEL-TJamieson Wellness Inc. $33.85
K-TKinross Gold Corp $9.37
KL-TKirkland Lake Gold Inc $51.60
GUD-TKnight Therapeutics Inc $5.33
LGD-TLiberty Gold Corp. $1.73
LUG-TLundin Gold Inc $10.54
MDI-TMajor Drilling Group International Inc $6.14
LABS-TMediPharm Labs Corp. $0.53
NEPT-TNeptune Wellness Solutions Inc. $2.07
NGT-TNewmont Corp. $76.69
NG-TNovagold Resources Inc $13.17
OR-TOsisko Gold Royalties Ltd $13.86
PAAS-TPan American Silver Corp $38.06
PVG-TPretium Resources Inc $14.46
REAL-TReal Matters $20.40
ROXG-TRoxgold Inc. $1.57
SSL-TSandstorm Gold Ltd $9.34
SSRM-TSSR Mining Inc. $23.32
TXG-TTorex Gold Resources Inc $17.61
WPM-TWheaton Precious Metals Corp. $51.85
YRI-TYamana Gold Inc $6.63

Source: Bloomberg

Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow the author of this article:

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Tickers mentioned in this story
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies